The Walmart Frozen Shrimp Subject To Recall Due To Potential Radioactive Risks
During regular inspections, the U.S. Customs & Border Protection (CBP) detected Cesium-137 (Cs-137) in a single sample of breaded shrimp, and all related containers and products were prevented from entering the United States. Cs-137 is a manmade radioisotope of cesium that's so widespread that it can be found in the air, soil, and food.
After the FDA was alerted to the presence of this chemical, its own testing found about 68.48 Bq/kg — much lower than the 1200 Bq/kg threshold — in the breaded product (per the FDA advisory). Although the chemical wasn't found in other products tested, the agency says some could still be contaminated, representing a potential health concern but not an acute hazard. Since the investigation is ongoing, it's unclear if this frozen shrimp will become one of the worst seafood recalls that swept across America or even be among the biggest Walmart Great Value brand recalls in history.
Read more: 14 Canned Foods To Stock Up On Before They Go Up In Price
Specific Products Affected And What To Do
The convenience and versatility of frozen shrimp make it a staple for many households. When you're looking for high-quality frozen shrimp to buy, though, reading the package label and looking for quality characteristics won't always protect you when some kind of contamination has occurred.
The 2-pound bags of Great Value Raw Ez Peel Tail-On Farm-Raised White Vannamei Shrimp that the FDA is concerned about are processed by PT. Bahari Makmur Sejati, an Indonesian company that does business as BMS Foods. The lot codes are 8005540-1, 8005538-1, and 8005539-1 — all with a Best by Date of March 15, 2027.
Exposure to possible low-level radiation from Cs-137 in these products could impact consumers' health with prolonged exposure. Because of that, the FDA suggests that customers who have purchased any of these packages throw them away; do not eat or serve them. It also advises that customers contact their healthcare teams if they have already eaten these products and experience adverse symptoms. Meanwhile, the FDA has recommended that Walmart issue a recall and that all distributors and retailers not sell or serve the products.
Hungry for more? Sign up for the free Daily Meal newsletter for delicious recipes, cooking tips, kitchen hacks, and more, delivered straight to your inbox.
Read the original article on The Daily Meal.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
San Diego-Area Biotech Startup Achieves Major Breakthrough in the Fight Against Rare Neurodevelopmental Disorder
SAN MARCOS, Calif., Aug. 20, 2025 /PRNewswire/ -- Grann Pharmaceuticals today announced a historic milestone in the development of transformative therapies for a rare and debilitating genetic disorder known as Rett Syndrome. The company's very first patient, Eleanor Elnekaveh, has successfully completed the experimental treatment regimen of RTT-1 (Eleanor), an mRNA lipid nanoparticle (LNP) protein replacement therapy. Grann was able to achieve this accomplishment from proof of concept to treatment in only 18 months. Rett Syndrome is a devastating, progressive neurodevelopmental disorder caused by mutations in the MECP2 gene. It primarily affects females and is characterized by the loss of previously acquired motor and communication skills, seizures, breathing irregularities, muscle stiffness, and severe cognitive impairment. There is currently no cure, and available treatments are limited to symptom management. RTT-1 (Eleanor) represents a potential paradigm shift in how this disease is treated by addressing the root cause of the disease. Eleanor tolerated the therapy well— a critical first step toward making this innovative therapeutic available to more patients. Grann Pharmaceuticals plans to apply for long-term continuation of Eleanor's treatment and is preparing for discussions with the U.S. Food and Drug Administration (FDA) on advancing RTT-1 (Eleanor) through the regulatory process. "This is a pivotal moment for our company, for the Rett community, and for the field of medical genetics," said Thomas Lyle Temple, CEO of Grann Pharmaceuticals. "We are committed to accelerating development so we can deliver innovative mRNA LNP therapies to Eleanor and children like her who face this catastrophic disease. For the first time, families affected by Rett Syndrome can have new hope where none previously existed." Grann Pharmaceuticals is actively seeking partnerships to support the next phases of development and expand access to RTT-1 as quickly and safely as possible. The company extends its gratitude to its partners at California State University San Marcos' Infinity Lab, Salus ASC, Combined Brain, Mitchell Blair, Dr. Raj Batra, Monica Joanna Elnekaveh, and the Elnekaveh family (Founders of CURE GABA-A) for their instrumental roles in making this breakthrough possible. About Grann PharmaceuticalsGrann Pharmaceuticals is a biotechnology company pioneering mRNA lipid nanoparticle–based treatments for patients with diseases caused by the absence of a critical human protein. The company's mission is to improve the quality of life by reversing medical conditions caused by genetic abnormalities and mutations. Grann Pharmaceuticals was inspired by the resilience and legacy of Grannan, the grandmother of CEO Thomas Lyle Temple, who lost her battle with neuroblastoma cancer in 2018. Contact Grann Pharmaceuticals To learn more about our mission and pipeline, please visit: all media inquiries or additional information, please contact: Patrick GranahanChief Operating OfficerGrann Pharmaceuticals River DannerBusiness Development ManagerGrann Pharmaceuticals View original content to download multimedia: SOURCE Grann Pharmaceuticals Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Indianapolis Star
41 minutes ago
- Indianapolis Star
Is your shrimp radioactive? FDA recalls seafood for possible contamination. Where it was sold
Check your shrimp. The Food and Drug Administration is recalling frozen shrimp sold at Walmart for possible radioactive chemical contamination. The FDA advised the recall in an Aug. 19 notice, saying certain raw frozen shrimp products processed by an Indonesian company, PT. Bahari Makmur Sejati (doing business as BMS Foods), had tested positive for Cesium-137, or Cs-137. Walmart sells the products under its Great Value brand. The presence of the chemical element violates the Federal Food, Drug, and Cosmetic Act, said the FDA, as it appears the affected product may have been "prepared, packed, or held under insanitary conditions whereby it may have become contaminated with Cs-137 and may pose a safety concern." Here's what we know. Two-pound bags of Great Value brand Frozen Raw Ez Peel Tail-On Farm-Raised White Vannamei Shrimp are subject to the recall. Lot codes and best by dates include the following: According to Walmart, the shrimp products made by PT. Bahari Makmur Sejati were distributed in 13 states. Indiana stores were not among them. But neighboring state Kentucky is. Cs-137 is a radioisotope of cesium, meaning it is a chemical element that emits radiation as it breaks down. It is man-made and is produced by nuclear fission, according to the FDA. In the United States, it is used in medical devices and measurement gauges, such as industrial devices that measure the thickness of materials. Because it is widespread around the globe, trace amounts can be found in the environment, including soil, food and air, said the FDA. Agencies, including the FDA and U.S. Customs & Border Protection, test for, monitor and regulate the presence of the substance due to the risks associated with long-term exposure. Story continues after photo gallery. The FDA said low-level radiation exposure over time can lead to serious health complications. Exposure to Cs-137 alone can cause burns, acute radiation sickness, cancer and death. As a result, the governing agencies restrict potential exposure to lessen the possibility of these long-term impacts. The FDA said the presence of Cs-137 was confirmed in one sample of breaded shrimp, which was denied entry into the United States. "FDA has concluded that the level detected in the breaded shrimp sample could represent a potential health concern for those exposed to this level of Cs-137 from consumption of the shrimp over an extended period of time combined with radiation that exists in the environment and from other sources such as medical procedures," the agency said in a statement. While Cs-137 was only detected in a single shipment thus far, that does not mean other products made by the same manufacturer are not impacted. PT. Bahari Makmur Sejati has been placed on an import alert that prevents any of their food products from entering the United States until it resolves any conditions that could have caused the exposure. Those with packages of the recalled Walmart shrimp at home should throw them away; do not consume them, said the FDA. Distributors and retailers should dispose of the products and should not sell or serve them. Those who fear they may have been exposed to elevated levels of cesium should contact their medical providers. To make a complaint or report an adverse reaction, consumers can visit the FDA's Industry and Consumer Assistance portal. More in news about food: Devour Indy Summerfest 2025 takes flight. The restaurants, special deals and menus you should know
Yahoo
an hour ago
- Yahoo
UK Food Safety Testing Market Size to Reach US$2.8 Billion by 2033
Shaped by strict Food Standards Agency (FSA) regulations and post-Brexit import complexities, the UK market emphasizes robust allergen management and supply chain traceability. High consumer awareness and advanced rapid testing methods are integral to maintaining confidence. Chicago, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The UK food safety testing market was valued at US$ 1,306.23 million in 2024 and is expected to reach US$ 2,801.82 million by 2033, growing at a CAGR of 9.23% during the forecast period 2025–2033. A dramatic surge in foodborne pathogens is a primary catalyst for growth. The frequency and scale of recent outbreaks are alarming. Official data show 70,352 laboratory-confirmed cases of Campylobacter in England during 2024, marking a decade-long high. Similarly, Salmonella infections in England peaked at 10,388 reported cases in 2024. Specific outbreaks highlight the severity of the situation. A 2024 Salmonella Blockley event resulted in 54 cases across the UK. These cases were distributed with 36 in England, 11 in Scotland, and 7 in Wales. The outbreak led to the hospitalization of ten individuals. Download Sample Pages: Even more concerning was a major Shiga toxin-producing E. coli (STEC) O145 outbreak in summer 2024, which caused over 250 illnesses in the UK food safety testing market. By late June 2024, confirmed cases reached 275. The geographical breakdown shows 182 cases in England, 58 in Scotland, and 31 in Wales. The outbreak's severity is underscored by the 122 people hospitalized. Furthermore, seven confirmed cases of haemolytic uraemic syndrome (HUS) were directly linked to the STEC O145 event. The Food Standards Agency (FSA) is actively investigating an increased number of incidents. Investigations into Listeria-related outbreaks grew to 17 in the 2024/25 period. STEC-related outbreak investigations rose to 13, and Salmonella outbreak investigations increased to 11 in the same timeframe. Adding to the domestic pressure, 2,703 cases of travel-associated gastrointestinal infections were recorded in England in 2024, with 183 of these being travel-related STEC infections. Key Findings in UK Food Safety Testing Market Market Forecast (2033) US$ 2,801.82 million CAGR 9.23% By Test Method Microbiological Test (36.64%) By Product Type Processed Food (25.56%) By Containment Type Biological Contaminants (36.85%) By Technology Traditional Testing (54.63%) By Service Sourcing Inhouse (57.75%) By Application Pathogen Detection (44.03%) By End User Food & Beverage (66.6%) Top Drivers Stringent post-Brexit import controls require comprehensive testing regimes. High consumer demand for transparency and clean-label products. Growth of plant-based and free-from food categories necessitates testing. Top Trends Adoption of whole-genome sequencing for precise outbreak source tracking. Focus on developing rapid tests for emerging environmental contaminants. Increased use of data analytics for predictive risk modeling. Top Challenges Navigating regulatory divergence between the UK and the EU. Persistent labor shortages impacting food industry and laboratory staffing. Combatting sophisticated food fraud and economically motivated adulteration. Chemical Contaminant Risks Mandate Broader and More Sophisticated Testing Protocols The threat is not limited to pathogens; chemical contaminants demand equal attention in the UK food safety testing market. Growing concerns over pesticides, industrial chemicals, and mycotoxins are expanding the required scope of testing services. In 2024, the FSA issued 14 food alerts for metal contamination alone, with 4 of these occurring by April. Analysis of imported food revealed residues of 48 pesticides not approved for use in the UK. A deeper look found residues from 46 cancer-linked pesticides in imported produce. In comparison, 19 cancer-linked pesticides were detected in food originating from the UK in 2024. The issue of "forever chemicals" has become prominent. A 2024 analysis discovered 10 different PFAS pesticides in fruit and vegetables sold in the UK food safety testing market. The nation currently approves 25 PFAS pesticides for use, with 6 of them classified as 'highly hazardous'. Government testing confirmed the presence of PFAS chemicals in over 3,300 food and drink samples in 2024. These findings came from a program that tested approximately 3,000 samples of food and produce. Meanwhile, the UK's annual testing for heavy metals covers a mere 400 to 450 samples of meat, milk, fish, and honey. A potential source of contamination is the UK's over 8,500 abandoned mines, which can leach toxic metals into the food chain. Specific food surveys also raise red flags. In a 2024 retail food survey, 13 out of 30 soy samples tested contained elevated levels of the mycotoxin ochratoxin A. A separate test of 90 samples for physical contaminants found one sample to be non-compliant. Escalating Product Recalls and Allergy Alerts Underscore Critical Testing Needs The sheer volume of product recalls provides a stark indicator of systemic weaknesses. These events in the UK food safety testing market are not only more frequent but also larger in scale, fuelling investment in preventive testing. In 2024, just three large-scale recall alerts implicated a staggering 424 different products. The average number of products recalled per event in 2024 was 2.5 times higher than in 2023. In the 2023/24 period, the FSA and Food Standards Scotland (FSS) issued a combined total of 136 food alerts. Within that total, 66 were specific Allergy Alerts. The focus on allergens intensified significantly, with 101 Allergy Alerts issued by the FSA and FSS in 2024. Beyond allergens, there were 67 product recalls in 2024 due to issues like foreign bodies and microbial contamination. The problem is widespread. In the first quarter of 2025, a total of 1,242 food and beverage recalls were recorded across the EU and UK. Non-bacterial contamination was responsible for 550 of these recalls. Aflatoxins were the culprit in 135 recall events. Bacterial contamination led to 237 recalls, with Salmonella being the cause of 174 of those incidents. Undeclared allergens prompted 94 recalls in Q1 2025, with milk being the most frequent issue, causing 19 separate recalls. Such figures make a compelling case for the expanding UK food safety testing market. Strict Regulatory Enforcement and Incident Management Spur Compliance-Driven Testing Demand Regulatory bodies are intensifying their oversight, making robust testing a non-negotiable aspect of compliance. The FSA's incidents response unit managed 1,837 food and feed incidents in the 2023/24 financial year. In the subsequent 2024/25 period, the FSA received notifications for 1,825 incidents across England, Wales, and Northern Ireland. Beyond direct notifications, the agency monitored 12,504 food safety signals in 2024/25. These signals prompted 810 intelligence assessments, which in turn launched 36 new investigations. Ultimately, these monitored signals resulted in 18 new incidents that required product withdrawal from the market. Local authorities are also increasing formal enforcement actions, which rose to 5,898 for food hygiene in 2023/24. Actions related to food standards in the food safety testing market grew to 658 in the same period. The financial consequences of non-compliance are severe. In a high-profile 2024 case, retailer ASDA was fined £640,000 for selling over 100 out-of-date food items. Asda was also ordered to pay an additional £15,115 in prosecution costs. The case was not an isolated one; it followed two other 2024 instances where Asda was fined £250,000 and £410,000 for similar food safety breaches. These penalties send a clear message to the industry. Specialized Food Crime and Fraud Investigations Are Now Major Market Drivers A growing area of focus is the criminal threat to the food supply chain. Specialized units are actively tackling food fraud, creating a niche for advanced authenticity and integrity testing. The UK's food crime units were running 29 live investigations during 2024. A significant portion of these, 20 investigations, involved meat and meat products. The scale of these operations is considerable. In a single food crime case in November 2024, officers seized 48 illegal sheep carcasses. As part of that National Food Crime Unit (NFCU) investigation into illegal meat, five men were arrested in London. The NFCU is also securing financial penalties against perpetrators. In a 2025 case, the unit obtained a confiscation order of over £30,000 from an individual selling illegal 'smokie' meat products. The action marked the third high-profile 'smokie' meat fraud case pursued by the NFCU within a single year. These enforcement successes highlight the critical need for sophisticated testing solutions that can verify the origin, composition, and legality of food products, a key growth area for the UK food safety testing market. Strained Local Authority Resources Create Significant Gaps in Public Food Safety While regulatory demands are increasing, the capacity of public enforcement bodies is strained. Under-resourced local authorities in the UK food safety testing market are struggling to maintain oversight, shifting a greater burden of responsibility onto businesses and their internal testing programs. As of 2024, there is a backlog of 95,000 overdue food business inspections across England, Wales, and Northern Ireland. Worryingly, this backlog includes 871 businesses classified as high-risk. In Scotland, 12,533 registered food businesses remained unrated as of December 2024. The number of unrated establishments awaiting a first inspection in England, Wales, and Northern Ireland had grown to around 41,000 by April 2024. This resource strain is directly impacting surveillance. The total number of food samples taken by local authorities across the UK dropped to 37,911 in the 2023/24 period. This figure is down from 40,144 samples in the prior period, showing a continuing decline in public testing capacity. Concurrently, consumer complaints are rising. There was an increase of 1,540 consumer complaints related to food hygiene in 2023/24, reaching a total of 60,919. Complaints regarding food standards and authenticity also rose by 200, to a total of 11,188 in the same period. Competitive Landscape Heats Up as Key Players Expand to Meet Demands Leading providers in the UK food safety testing market are responding to these challenges with strategic expansions and innovations. Key players are enhancing their capabilities to capture growing demand, particularly in identified hotspot sectors. In July 2025, Eurofins Food Testing UK demonstrated a clear growth strategy by finalizing its acquisition of the Bio Search food testing laboratory in Belfast. The move significantly expands its capabilities and footprint in Northern Ireland. In 2024, Eurofins also launched a new method for enumerating acetic acid bacteria, a service specifically targeting the needs of the UK beverage industry. These expansions are timely, as certain food categories are under intense scrutiny. A 2024 FSA survey found that 16 out of 40 samples of frozen raw chicken, a total of 40%, were non-compliant due to issues like undeclared water. The same survey revealed that 10 out of 24 frozen beef burger samples, or 42%, were non-compliant. Among the non-compliant burger samples, eight were found to have less meat content than what was declared on the label. These sector-specific failings create clear opportunities for specialized testing services. Advanced Whole Genome Sequencing Technology Revolutionizes Outbreak Response and Investigation The evolution of the UK food safety testing market is intrinsically linked to technological advancement. While widespread adoption rates are proprietary, official reports confirm the critical role of next-generation methods. Advanced testing technologies, particularly whole genome sequencing (WGS), are no longer on the horizon; they are central to modern surveillance and response. The UK Health Security Agency (UKHSA) extensively used WGS to successfully identify and manage the 2024 outbreaks of Salmonella Blockley and E. coli O145. The application of WGS in these high-profile incidents demonstrates the technology's power. It allows for a level of precision in linking cases and identifying the source of an outbreak that was previously impossible. This capability is transforming public health investigations. The clear success and growing reliance on WGS signal a market-wide shift. The move is away from traditional culturing methods and toward more rapid, accurate, and data-rich technologies. This technological pivot is a fundamental driver of investment and innovation across the entire food safety sector. Need a Customized Version? Request It Now: Post-Brexit Regulations and Future Trends Shaping the UK Food Safety Market The future of the UK food safety testing market will be shaped by an evolving regulatory framework and the continuation of current trends. Post-Brexit adjustments are creating new compliance hurdles and, consequently, new testing requirements. As of January 1, 2024, a significant new rule took effect. All pre-packaged food sold in Great Britain must now include a UK address for the Food Business Operator. The change introduces new labeling verification needs for the entire industry. Looking ahead, the market's growth trajectory appears strong and certain. The convergence of the key drivers—relentless pathogen pressure, expanding chemical threats, massive product recalls, tough enforcement, and public sector gaps—creates a compelling case for sustained investment. Businesses have no alternative but to integrate more frequent, more sophisticated, and more comprehensive testing into their operations. The demand is not just for testing, but for a true partnership in risk mitigation, making the UK food safety testing market a critical component of national food security and public health for years to come. UK Food Safety Testing Market Major Players: ALS Laboratories (UK) Limited Bureau Veritas UK Limited Campden BRI Group Eurofins Food Testing UK Limited Fera Science Limited Food Forensics Limited Intertek Group Plc. Northern Hygiene Laboratories Limited SGS United Kingdom Limited TÜV SÜD UK Limited Other Prominent Players Key Market Segmentation: By Test Method Microbiological Test Total Plate Count (TPC) Coliform Testing Listeria Testing Salmonella Testing Campylobacter Testing Sensory Test Manual Smell Taste Appearance Others Instrumental Smell Taste Appearance Others Physical Test Chemical Test Allergen Test Others By Product Type Processed Food Fruits &Vegetables Beverages Grains & Cereal Confectionery Meat & Meat Products Milk & Milk Products Others By Technology Traditional Testing Rapid Testing By Service Sourcing Inhouse Outsource By End User Food & Beverage Academic and Research Institutions Testing Laboratories Need a Detailed Walkthrough of the Report? Request a Live Session: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website:
